Comparative bioavailability study of clonazepam after oral administration of two tablet formulations.
J Assoc Physicians India
; 48(10): 985-7, 2000 Oct.
Article
em En
| MEDLINE
| ID: mdl-11200924
ABSTRACT
OBJECTIVE:
To assess the bioavailability of clonazepam from two brands of 2 mg tablet formulations--Epitril and reference brand.METHODS:
A two-way randomised cross-over bioavailability study was carried out in 12 healthy male volunteers. Coded plasma samples were analysed for levels of clonazepam by high performance liquid chromatography (HPLC) method.RESULTS:
The mean Cmax, Tmax t1/2 beta and AUC (0-48) for Epitril were 16.31 +/- 3.07 ng/mL, 1.63 +/- 0.48 h, 46.97 +/- 12.26 h and 207.70 +/- 57.07 ng/ml.h; for reference brand were 19.75 +/- 5.95 ng/mL, 1.42 +/- 0.29 h, 46.88 +/- 11.29 h and 215.70 +/- 50.89 ng/ml.h respectively. These were comparable and the differences were not statistically significant.CONCLUSION:
Based on above pharmacokinetic parameters, Epitril was bioequivalent to reference brand.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Clonazepam
Idioma:
En
Ano de publicação:
2000
Tipo de documento:
Article